关注
Dr Alexander Kharlamov, MD FESC FACC FEACVI
Dr Alexander Kharlamov, MD FESC FACC FEACVI
De Haar Research Task Force (DHRF)
在 dhrfpro.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Silica–gold nanoparticles for atheroprotective management of plaques: results of the NANOM-FIM trial
AN Kharlamov, AE Tyurnina, VS Veselova, OP Kovtun, VY Shur, ...
Nanoscale 7 (17), 8003-8015, 2015
2352015
Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter
PA Lemos, V Farooq, CK Takimura, PS Gutierrez, R Virmani, F Kolodgie, ...
EuroIntervention 9 (1), 148-156, 2013
1242013
Progress in treatment by percutaneous coronary intervention: the stent of the future
T Muramatsu, Y Onuma, YJ Zhang, CV Bourantas, A Kharlamov, R Diletti, ...
Revista Española de Cardiología (English Edition) 66 (6), 483-496, 2013
892013
Plasmonic photothermal therapy of atherosclerosis with nanoparticles: long-term outcomes and safety in NANOM-FIM trial
AN Kharlamov, JA Feinstein, JA Cramer, JA Boothroyd, EV Shishkina, ...
Future cardiology 13 (4), 345-363, 2017
802017
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey
M Valgimigli, F Costa, R Byrne, M Haude, A Baumbach, S Windecker, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2015
602015
Plasmonic photothermic and stem cell therapy of atherosclerotic plaque as a novel nanotool for angioplasty and artery remodeling
AN Kharlamov, JL Gabinsky
Rejuvenation research 15 (2), 222-230, 2012
512012
Freeing the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds?
Y Onuma, T Muramatsu, A Kharlamov, PW Serruys
Cardiovascular intervention and therapeutics 27, 141-154, 2012
362012
Cardiovascular burden and percutaneous interventions in Russian Federation: systematic epidemiological update
AN Kharlamov
Cardiovascular Diagnosis and Therapy 7 (1), 60-84, 2017
242017
Avances en el tratamiento mediante intervención coronaria percutánea: el stent del futuro
T Muramatsu, Y Onuma, YJ Zhang, CV Bourantas, A Kharlamov, R Diletti, ...
Revista Española de Cardiología 66 (6), 483-496, 2013
202013
Plasmonic photothermal therapy for atheroregression below Glagov threshold
AN Kharlamov
Future Cardiology 9 (3), 405-425, 2013
202013
Plasmonics for treatment of atherosclerosis: Results of NANOM-FIM trial
AN Kharlamov, AE Tyurnina, VS Veselova, OS Novoselova, AS Filatova, ...
Journal of Nanomedicine and Nanotechnology 4 (1), 2013
152013
Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management …
M Adamo, RA Byrne, A Baumbach, M Haude, S Windecker, M Valgimigli
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2019
142019
Do we have a future with transcatheter adventitial delivery of stem cells?
AN Kharlamov, HJ Duckers, HMM van Beusekom, PC Smits, EC Perin, ...
International journal of cardiology 165 (2), 217-221, 2013
122013
Nanoparticles for Treatment of Atherosclerosis: Challenges of Plasmonic Photothermal Therapy in Translational Studies
A Kharlamov, I Zubarev, E Shishkina, V Shur
Future Cardiology, 2018
112018
Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials?
AN Kharlamov
Interventional cardiology 7 (5), 469-482, 2015
92015
Plasmonic Photothermal Therapy of Atherosclerosis and Preparation of Target Lesion in Patients with Arterial Remodeling: Subanalysis of Nanom-Fim Trial
A Kharlamov
Atherosclerosis 287, e34, 2019
62019
Glimpse into the Future of Nanotheranostic Strategies for Regression of Atherosclerosis through the Prism of Systems Biomedicine: Systematic Review of Innovations from …
K AN
Current Nanomedicine 6 (3), 186-218, 2016
6*2016
Vitamin D in the treatment of cardiorenal syndrome in patients with chronic nephropathy
AN Kharlamov, AN Perrish, G IaL, R Kh, I EIu
Kardiologiia 52 (3), 33-44, 2012
62012
Bioresorbable scaffolds for atheroregression: understanding of transient scaffolding
AN Kharlamov
Current Cardiology Reviews 12 (1), 66-82, 2016
42016
Phenomenon of elongated struts: Is optical coherence tomography accurate enough to analyze scaffold area?
AN Kharlamov
International journal of cardiology 168 (4), 4280-4284, 2013
42013
系统目前无法执行此操作,请稍后再试。
文章 1–20